125 related articles for article (PubMed ID: 8546800)
1. A highly divergent antigenic site of foot-and-mouth disease virus retains its immunodominance.
Borrego B; Camarero JA; Mateu MG; Domingo E
Viral Immunol; 1995; 8(1):11-8. PubMed ID: 8546800
[TBL] [Abstract][Full Text] [Related]
2. Direct evaluation of the immunodominance of a major antigenic site of foot-and-mouth disease virus in a natural host.
Mateu MG; Camarero JA; Giralt E; Andreu D; Domingo E
Virology; 1995 Jan; 206(1):298-306. PubMed ID: 7831785
[TBL] [Abstract][Full Text] [Related]
3. A single amino acid substitution affects multiple overlapping epitopes in the major antigenic site of foot-and-mouth disease virus of serotype C.
Mateu MG; Martínez MA; Capucci L; Andreu D; Giralt E; Sobrino F; Brocchi E; Domingo E
J Gen Virol; 1990 Mar; 71 ( Pt 3)():629-37. PubMed ID: 1690261
[TBL] [Abstract][Full Text] [Related]
4. Monoclonal antibodies, against O1 serotype foot-and-mouth disease virus, from a natural bovine host, recognize similar antigenic features to those defined by the mouse.
Barnett PV; Samuel AR; Pullen L; Ansell D; Butcher RN; Parkhouse RM
J Gen Virol; 1998 Jul; 79 ( Pt 7)():1687-97. PubMed ID: 9680132
[TBL] [Abstract][Full Text] [Related]
5. Antigenic heterogeneity of a foot-and-mouth disease virus serotype in the field is mediated by very limited sequence variation at several antigenic sites.
Mateu MG; Hernández J; Martínez MA; Feigelstock D; Lea S; Pérez JJ; Giralt E; Stuart D; Palma EL; Domingo E
J Virol; 1994 Mar; 68(3):1407-17. PubMed ID: 8107204
[TBL] [Abstract][Full Text] [Related]
6. Selection of antigenic variants of foot-and-mouth disease virus in the absence of antibodies, as revealed by an in situ assay.
Diez J; Mateu MG; Domingo E
J Gen Virol; 1989 Dec; 70 ( Pt 12)():3281-9. PubMed ID: 2481712
[TBL] [Abstract][Full Text] [Related]
7. Antigenic site variation in foot-and-mouth disease virus serotype O grown under vaccinal serum antibodies in vitro.
Sarangi LN; Mohapatra JK; Subramaniam S; Sanyal A; Pattnaik B
Virus Res; 2013 Sep; 176(1-2):273-9. PubMed ID: 23850868
[TBL] [Abstract][Full Text] [Related]
8. Antigenic structure of foot and mouth disease virus type A22 (Indian isolates).
Tulasiram P; Suryanarayana V
Indian J Exp Biol; 1998 Jan; 36(1):70-5. PubMed ID: 9536655
[TBL] [Abstract][Full Text] [Related]
9. Host cell selection of antigenic variants of foot-and-mouth disease virus.
Bolwell C; Brown AL; Barnett PV; Campbell RO; Clarke BE; Parry NR; Ouldridge EJ; Brown F; Rowlands DJ
J Gen Virol; 1989 Jan; 70 ( Pt 1)():45-57. PubMed ID: 2471782
[TBL] [Abstract][Full Text] [Related]
10. Antigenicity modulation upon peptide cyclization: application to the GH loop of foot-and-mouth disease virus strain C1-Barcelona.
Gomes P; Giralt E; Andreu D
Vaccine; 2001 May; 19(25-26):3459-66. PubMed ID: 11348711
[TBL] [Abstract][Full Text] [Related]
11. The structure and antigenicity of a type C foot-and-mouth disease virus.
Lea S; Hernández J; Blakemore W; Brocchi E; Curry S; Domingo E; Fry E; Abu-Ghazaleh R; King A; Newman J
Structure; 1994 Feb; 2(2):123-39. PubMed ID: 8081743
[TBL] [Abstract][Full Text] [Related]
12. Neutralizing epitopes of type O foot-and-mouth disease virus. I. Identification and characterization of three functionally independent, conformational sites.
Barnett PV; Ouldridge EJ; Rowlands DJ; Brown F; Parry NR
J Gen Virol; 1989 Jun; 70 ( Pt 6)():1483-91. PubMed ID: 2471811
[TBL] [Abstract][Full Text] [Related]
13. Antibodies raised in a natural host and monoclonal antibodies recognize similar antigenic features of foot-and-mouth disease virus.
Mateu MG; Andreu D; Domingo E
Virology; 1995 Jun; 210(1):120-7. PubMed ID: 7793064
[TBL] [Abstract][Full Text] [Related]
14. Distinct repertoire of antigenic variants of foot-and-mouth disease virus in the presence or absence of immune selection.
Borrego B; Novella IS; Giralt E; Andreu D; Domingo E
J Virol; 1993 Oct; 67(10):6071-9. PubMed ID: 7690417
[TBL] [Abstract][Full Text] [Related]
15. Neutralization escape mutants of type A influenza virus are readily selected by antisera from mice immunized with whole virus: a possible mechanism for antigenic drift.
Lambkin R; McLain L; Jones SE; Aldridge SL; Dimmock NJ
J Gen Virol; 1994 Dec; 75 ( Pt 12)():3493-502. PubMed ID: 7527838
[TBL] [Abstract][Full Text] [Related]
16. Development of replication-defective adenovirus serotype 5 containing the capsid and 3C protease coding regions of foot-and-mouth disease virus as a vaccine candidate.
Mayr GA; Chinsangaram J; Grubman MJ
Virology; 1999 Oct; 263(2):496-506. PubMed ID: 10544121
[TBL] [Abstract][Full Text] [Related]
17. Reactivity with monoclonal antibodies of viruses from an episode of foot-and-mouth disease.
Mateu MG; Rocha E; Vicente O; Vayreda F; Navalpotro C; Andreu D; Pedroso E; Giralt E; Enjuanes L; Domingo E
Virus Res; 1987 Sep; 8(3):261-74. PubMed ID: 2446442
[TBL] [Abstract][Full Text] [Related]
18. Antigenic properties and population stability of a foot-and-mouth disease virus with an altered Arg-Gly-Asp receptor-recognition motif.
Ruiz-Jarabo CM; Sevilla N; Dávila M; Gómez-Mariano G; Baranowski E; Domingo E
J Gen Virol; 1999 Aug; 80 ( Pt 8)():1899-1909. PubMed ID: 10466785
[TBL] [Abstract][Full Text] [Related]
19. Monoclonal antibodies to an Indian strain of type A foot-and-mouth disease virus.
Tosh C; Venkataramanan R; Pattnaik B; Hemadri D; Sanyal A
Acta Virol; 1999 Aug; 43(4):219-25. PubMed ID: 10749367
[TBL] [Abstract][Full Text] [Related]
20. Response of foot-and-mouth disease virus C3 Resende to immunological pressure exerted in vitro by antiviral polyclonal sera.
Schiappacassi M; Rieder Rojas E; Carrillo E; Campos R
Virus Res; 1995 Apr; 36(1):77-85. PubMed ID: 7542827
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
